217 related articles for article (PubMed ID: 33544757)
21. Detection of copy number variations in epilepsy using exome data.
Tsuchida N; Nakashima M; Kato M; Heyman E; Inui T; Haginoya K; Watanabe S; Chiyonobu T; Morimoto M; Ohta M; Kumakura A; Kubota M; Kumagai Y; Hamano SI; Lourenco CM; Yahaya NA; Ch'ng GS; Ngu LH; Fattal-Valevski A; Weisz Hubshman M; Orenstein N; Marom D; Cohen L; Goldberg-Stern H; Uchiyama Y; Imagawa E; Mizuguchi T; Takata A; Miyake N; Nakajima H; Saitsu H; Miyatake S; Matsumoto N
Clin Genet; 2018 Mar; 93(3):577-587. PubMed ID: 28940419
[TBL] [Abstract][Full Text] [Related]
22. Prenatal genetic testing in 19 fetuses with corpus callosum abnormality.
She Q; Tang E; Peng C; Wang L; Wang D; Tan W
J Clin Lab Anal; 2021 Nov; 35(11):e23971. PubMed ID: 34569664
[TBL] [Abstract][Full Text] [Related]
23. Impact of 1q gains on treatment outcomes of patients with newly diagnosed multiple myeloma in a real-world Swedish population receiving modern treatment.
Lemonakis K; Olsson-Arvidsson L; Karlsson C; Johansson B; Hansson M
Eur J Haematol; 2023 Sep; 111(3):391-399. PubMed ID: 37271732
[TBL] [Abstract][Full Text] [Related]
24. [Adverse effects of double-hit combining ISS-Ⅲ stage and 1q gain or del (17p) on prognosis of patients with newly diagnosed multiple myeloma].
Liu XL; Yang YP; Bai J; Yue TT; Yang PY; Zhang Y; Fan HQ; Li W; Jin FY
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):912-917. PubMed ID: 31856439
[No Abstract] [Full Text] [Related]
25. Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.
Walker BA; Boyle EM; Wardell CP; Murison A; Begum DB; Dahir NM; Proszek PZ; Johnson DC; Kaiser MF; Melchor L; Aronson LI; Scales M; Pawlyn C; Mirabella F; Jones JR; Brioli A; Mikulasova A; Cairns DA; Gregory WM; Quartilho A; Drayson MT; Russell N; Cook G; Jackson GH; Leleu X; Davies FE; Morgan GJ
J Clin Oncol; 2015 Nov; 33(33):3911-20. PubMed ID: 26282654
[TBL] [Abstract][Full Text] [Related]
26. Copy number variations in normal karyotype acute myeloid leukaemia and their association with treatment response.
Kim KI; Kim TK; Kim IW; Ahn KS; Yoon SS; Shin WG; Oh JM
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):317-24. PubMed ID: 22672209
[TBL] [Abstract][Full Text] [Related]
27. The combination of C-Myc rearrangement and 1q21 gain is associated with poor prognosis in multiple myeloma.
Jin Y; Yu X; Du J; Li H; Tang W; Jia C; Zan Y; Chen M; Zhang Y; Yu M; Rong W; Zhou D; Zhuang J
Ann Hematol; 2021 May; 100(5):1251-1260. PubMed ID: 33686491
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Implications of Monosomies in Patients With Multiple Myeloma.
Shin SY; Eom HS; Sohn JY; Lee H; Park B; Joo J; Jang JH; Lee MN; Kim JK; Kong SY
Clin Lymphoma Myeloma Leuk; 2017 Mar; 17(3):159-164.e2. PubMed ID: 28089441
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of esterase gene expression in multiple myeloma.
Kumari R; Majumder MM; Lievonen J; Silvennoinen R; Anttila P; Nupponen NN; Lehmann F; Heckman CA
Br J Cancer; 2021 Apr; 124(8):1428-1436. PubMed ID: 33531688
[TBL] [Abstract][Full Text] [Related]
30. Identification of unbalanced genome copy number abnormalities in patients with multiple myeloma by single-nucleotide polymorphism genotyping microarray analysis.
Kamada Y; Sakata-Yanagimoto M; Sanada M; Sato-Otsubo A; Enami T; Suzukawa K; Kurita N; Nishikii H; Yokoyama Y; Okoshi Y; Hasegawa Y; Ogawa S; Chiba S
Int J Hematol; 2012 Oct; 96(4):492-500. PubMed ID: 22972171
[TBL] [Abstract][Full Text] [Related]
31. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.
Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P
Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587
[TBL] [Abstract][Full Text] [Related]
32. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.
Sawyer JR
Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186
[TBL] [Abstract][Full Text] [Related]
33. Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders.
Pugh TJ; Fink JM; Lu X; Mathew S; Murata-Collins J; Willem P; Fang M;
Cancer Genet; 2018 Dec; 228-229():184-196. PubMed ID: 30393007
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological features of plasmablastic multiple myeloma: a population-based cohort.
Møller HE; Preiss BS; Pedersen P; Kristensen IB; Hansen CT; Frederiksen M; Abildgaard N; Møller MB
APMIS; 2015 Aug; 123(8):652-8. PubMed ID: 26152595
[TBL] [Abstract][Full Text] [Related]
35. Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.
Kim SY; Min HJ; Park HK; Oh B; Kim TY; She CJ; Hwang SM; Kim M; Kim HK; Kim I; Yoon SS; Park S; Kim BK; Lee JH; Lee DS;
Biol Blood Marrow Transplant; 2011 Jun; 17(6):810-20. PubMed ID: 21220034
[TBL] [Abstract][Full Text] [Related]
36. Clinical evaluation of integrated panel testing by next-generation sequencing for somatic mutations in neuroblastomas with MYCN unamplification.
Cao Y; Jin Y; Yu J; Wang J; Qiu Y; Duan X; Ye Y; Cheng Y; Dong L; Feng X; Wang D; Li Z; Tian X; Wang H; Yan J; Zhao Q
Oncotarget; 2017 Jul; 8(30):49689-49701. PubMed ID: 28591696
[TBL] [Abstract][Full Text] [Related]
37. Exome copy number variation detection: Use of a pool of unrelated healthy tissue as reference sample.
Wenric S; Sticca T; Caberg JH; Josse C; Fasquelle C; Herens C; Jamar M; Max S; Gothot A; Caers J; Bours V
Genet Epidemiol; 2017 Jan; 41(1):35-40. PubMed ID: 27862228
[TBL] [Abstract][Full Text] [Related]
38. Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma.
Gutiérrez NC; García JL; Hernández JM; Lumbreras E; Castellanos M; Rasillo A; Mateo G; Hernández JM; Pérez S; Orfao A; San Miguel JF
Blood; 2004 Nov; 104(9):2661-6. PubMed ID: 15238415
[TBL] [Abstract][Full Text] [Related]
39. Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis.
Chang H; Li D; Zhuang L; Nie E; Bouman D; Stewart AK; Chun K
Leuk Lymphoma; 2004 May; 45(5):965-9. PubMed ID: 15291356
[TBL] [Abstract][Full Text] [Related]
40. CoDE-seq, an augmented whole-exome sequencing, enables the accurate detection of CNVs and mutations in Mendelian obesity and intellectual disability.
Montagne L; Derhourhi M; Piton A; Toussaint B; Durand E; Vaillant E; Thuillier D; Gaget S; De Graeve F; Rabearivelo I; Lansiaux A; Lenne B; Sukno S; Desailloud R; Cnop M; Nicolescu R; Cohen L; Zagury JF; Amouyal M; Weill J; Muller J; Sand O; Delobel B; Froguel P; Bonnefond A
Mol Metab; 2018 Jul; 13():1-9. PubMed ID: 29784605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
